We are live on ! Find out more
RMTI icon

Rockwell Medical

83 hedge funds and large institutions have $118M invested in Rockwell Medical in 2013 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more capital invested

Capital invested by funds: $36.7M → $118M (+$81.3M)

100% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 15

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

17% more funds holding

Funds holding: 7183 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

72% less call options, than puts

Call options by funds: $10.5M | Put options by funds: $36.8M

Holders
83
Holders Change
+12
Holders Change %
+16.9%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
30
Reduced
15
Closed
16
Calls
$10.5M
Puts
$36.8M
Net Calls
-$26.4M
Net Calls Change
-$26.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$12.8M +$796K +1,172 +13%
Alkeon Capital Management
2
Alkeon Capital Management
New York
$11.4M +$6.17M +9,091 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$8.69M +$227K +335 +5%
WSA
4
Wall Street Associates
California
$8.26M +$1.33M +1,965 +43%
PCM
5
Perkins Capital Management
Minnesota
$7.21M -$998K -1,470 -20%
State Street
6
State Street
Massachusetts
$6.85M +$170K +251 +5%
Northern Trust
7
Northern Trust
Illinois
$5.99M +$724K +1,066 +29%
BIT
8
BlackRock Institutional Trust
California
$5.85M -$689K -1,015 -18%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$4.59M +$1.18M +1,733 +90%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$3.76M +$876K +1,290 +76%
Jane Street
11
Jane Street
New York
$2.88M +$1.56M +2,299 New
EI
12
EAM Investors
California
$2.76M +$1.49M +2,199 New
RFC
13
Russell Frank Company
Washington
$2.16M +$1.17M +1,722 +172,200%
TCIM
14
TIAA CREF Investment Management
New York
$1.94M -$143K -210 -12%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.8M +$80.8K +119 +9%
EIM
16
Essex Investment Management
Massachusetts
$1.54M +$832K +1,225 New
Invesco
17
Invesco
Georgia
$1.52M +$824K +1,214 New
BIM
18
BlackRock Investment Management
Delaware
$1.51M +$11.5K +17 +1%
Ameriprise
19
Ameriprise
Minnesota
$1.36M +$718K +1,058 +4,809%
Allianz Asset Management
20
Allianz Asset Management
Germany
$1.28M +$694K +1,023 New
Group One Trading
21
Group One Trading
Illinois
$1.23M -$46.8K -69 -7%
Morgan Stanley
22
Morgan Stanley
New York
$1.09M -$102K -151 -15%
Barclays
23
Barclays
United Kingdom
$1.08M +$352K +519 +140%
BCM
24
BBT Capital Management
Texas
$1.03M +$555K +818 New
Millennium Management
25
Millennium Management
New York
$960K +$446K +657 +608%

RMTI Hedge Fund Activity: Q3 2013 in Review

83 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q3 2013, worth a combined $118M — up 221% from $36.7M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RMTI positions and 16 closed out — a net gain of 13 holders — while 30 added to existing stakes and 15 trimmed.

The largest buyer was Alkeon Capital Management, opening a new position worth an estimated $6.17M. The largest seller was Camber Capital Management, exiting entirely with an estimated $7.22M sold.

  • 83 institutional investors held Rockwell Medical (RMTI) as of Q3 2013, up from 71 in Q2 2013.
  • Funds reported $118M of Rockwell Medical stock for Q3 2013, up 221% quarter-over-quarter.
  • 29 funds opened new Rockwell Medical positions in Q3 2013 and 16 closed out, a net change of +13 holders.
  • The largest Rockwell Medical buyer in Q3 2013 was Alkeon Capital Management, an estimated $6.17M added.
  • The largest Rockwell Medical seller in Q3 2013 was Camber Capital Management, an estimated $7.22M sold.

Based on aggregated 13F filings for Q3 2013.